UBS Group’s Organon & Co OGN Stock Holding History

UBS Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-225,000	Closed	-$4.23M	–	9934
2024 Q1	$4.23M	Hold	225,000	–	–	﹤0.01%	3150
2023 Q4	$3.24M	Buy	+225,000	New	+$3.06M	﹤0.01%	3268
2022 Q2	–	Sell	-414	Closed	-$14K	–	10733
2022 Q1	$14K	Sell	414 -5,666	-93%	-$194K	﹤0.01%	7955
2021 Q4	$185K	Buy	6,080 +3,748	+161%	+$122K	﹤0.01%	5766
2021 Q3	$76K	Buy	2,332 +239	+11%	+$7.65K	﹤0.01%	6026
2021 Q2	$63K	Buy	+2,093	New	+$68.9K	﹤0.01%	6229

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

UBS Group's OGN Position: Q1 2026 in Review

UBS Group reduced its Organon & Co (OGN) stake by 19% in Q1 2026, selling an estimated $6.2M and leaving 3,471,579 shares worth $20.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

UBS Group first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $57.7M in Q2 2025. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

UBS Group held 3,471,579 shares of Organon & Co worth $20.8M as of Q1 2026.
UBS Group sold 823,423 Organon & Co shares in Q1 2026, an estimated $6.2M.
Organon & Co made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2534 holding.
UBS Group first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
UBS Group's Organon & Co position peaked at $57.7M in Q2 2025.
604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.